$RMD
RESMED INC Stock $rmd

$rmd Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000094381923000008 Filed on April 28, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$1.122B	$1.117B
YoY Change	22.66%	29.2%
Cost Of Revenue	$504.7M	$499.1M
YoY Change	28.67%	33.71%
Gross Profit	$617.4M	$617.8M
YoY Change	18.16%	25.76%
Gross Profit Margin	55.02%	55.31%
Selling, General & Admin	$240.7M	$228.5M
YoY Change	23.5%	25.25%
% of Gross Profit	38.98%	36.98%
Research & Development	$78.14M	$76.44M
YoY Change	21.5%	14.42%
% of Gross Profit	12.66%	12.37%
Depreciation & Amortization	$46.76M	$44.36M
YoY Change	24.99%	4.85%
% of Gross Profit	7.57%	7.18%
Operating Expenses	$331.2M	$317.1M
YoY Change	23.98%	23.41%
Operating Profit	$286.2M	$300.7M
YoY Change	12.07%	28.35%
Interest Expense	-$18.75M	-$8.729M
YoY Change	-5.17%	-259.81%
% of Operating Profit	-6.55%	-2.9%
Other Income/Expense, Net	$61.00K	-$11.29M
YoY Change	-97.53%	42.12%
Pretax Income	$276.8M	$289.4M
YoY Change	16.26%	27.86%
Income Tax	$47.14M	$56.88M
% Of Pretax Income	17.03%	19.66%
Net Earnings	$229.7M	$232.5M
YoY Change	17.74%	29.88%
Net Earnings / Revenue	20.47%	20.82%
Basic Earnings Per Share		$1.58
Diluted Earnings Per Share	$1.56	$1.58
COMMON SHARES
Basic Shares Outstanding	146.9M shares	146.9M shares
Diluted Shares Outstanding		147.4M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$227.9M	$227.9M
YoY Change	-16.74%	12.95%
Cash & Equivalents	$227.9M	$227.9M
Short-Term Investments
Other Short-Term Assets	$179.9M	$155.5M
YoY Change	37.07%	-48.74%
Inventory	$998.0M	$1.011B
Prepaid Expenses
Receivables	$704.9M	$686.3M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$2.368B	$2.338B
YoY Change	22.59%	37.17%
LONG-TERM ASSETS
Property, Plant & Equipment	$537.9M	$528.8M
YoY Change	7.96%	3.03%
Goodwill	$2.770B	$2.784B
YoY Change	43.06%	43.02%
Intangibles
YoY Change
Long-Term Investments	$65.37M	$67.70M
YoY Change	559.06%	442.57%
Other Assets	$262.5M	$270.9M
YoY Change	52.81%	59.9%
Total Long-Term Assets	$4.384B	$4.376B
YoY Change	38.54%	36.71%
TOTAL ASSETS
Total Short-Term Assets	$2.368B	$2.338B
Total Long-Term Assets	$4.384B	$4.376B
Total Assets	$6.752B	$6.714B
YoY Change	32.49%	36.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$150.8M	$161.9M
YoY Change	-5.33%	8.08%
Accrued Expenses	$365.7M	$347.4M
YoY Change	6.07%	6.46%
Deferred Revenue	$138.1M	$141.0M
YoY Change	27.06%	25.43%
Short-Term Debt	$9.902M	$9.901M
YoY Change	-0.14%	-17.26%
Long-Term Debt Due	$9.902M	$9.901M
YoY Change	-0.14%	-17.26%
Total Short-Term Liabilities	$758.5M	$761.7M
YoY Change	10.04%	14.15%
LONG-TERM LIABILITIES
Long-Term Debt	$1.431B	$1.576B
YoY Change	87.01%	135.66%
Other Long-Term Liabilities	$68.17M	$69.55M
YoY Change	1041.04%	1262.98%
Total Long-Term Liabilities	$1.863B	$2.020B
YoY Change	78.17%	110.56%
TOTAL LIABILITIES
Total Short-Term Liabilities	$758.5M	$761.7M
Total Long-Term Liabilities	$1.863B	$2.020B
Total Liabilities	$2.622B	$2.781B
YoY Change	51.1%	71.01%
SHAREHOLDERS EQUITY
Retained Earnings	$4.253B	$4.088B
YoY Change	17.69%	17.47%
Common Stock	$1.772B	$1.729B
YoY Change	5.33%	5.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.130B	$3.933B
YoY Change
Total Liabilities & Shareholders Equity	$6.752B	$6.714B
YoY Change	32.49%	36.87%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	$229.7M	$232.5M
YoY Change	17.74%	29.88%
Depreciation, Depletion And Amortization	$46.76M	$44.36M
YoY Change	24.99%	4.85%
Cash From Operating Activities	$237.4M	$282.6M
YoY Change	198.71%	140.61%
INVESTING ACTIVITIES
Capital Expenditures	$38.73M	$31.22M
YoY Change	-219.57%	-159.87%
Acquisitions
YoY Change
Other Investing Activities	-$7.789M	$3.120M
YoY Change	-65.91%	17.21%
Cash From Investing Activities	-$46.52M	-$28.10M
YoY Change	-15.78%	-43.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-188.6M	-279.6M
YoY Change	-427.99%	359.36%
NET CHANGE
Cash From Operating Activities	237.4M	282.6M
Cash From Investing Activities	-46.52M	-28.10M
Cash From Financing Activities	-188.6M	-279.6M
Net Change In Cash	2.322M	-25.10M
YoY Change	-97.16%	-454.16%
FREE CASH FLOW
Cash From Operating Activities	$237.4M	$282.6M
Capital Expenditures	$38.73M	$31.22M
Free Cash Flow	$198.7M	$251.3M
YoY Change	77.6%	48.2%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Entity Central Index Key EntityCentralIndexKey	0000943819
CY2023Q1	us-gaap	Derivative Asset Current Statement Of Financial Position Extensible Enumeration DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#PrepaidExpenseAndOtherAssetsCurrent
CY2022Q2	us-gaap	Derivative Asset Current Statement Of Financial Position Extensible Enumeration DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#PrepaidExpenseAndOtherAssetsCurrent
CY2022Q2	us-gaap	Derivative Asset Noncurrent Statement Of Financial Position Extensible Enumeration DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2023Q1	us-gaap	Derivative Asset Noncurrent Statement Of Financial Position Extensible Enumeration DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2023Q1	us-gaap	Derivative Liability Noncurrent Statement Of Financial Position Extensible Enumeration DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2022Q2	us-gaap	Derivative Liability Noncurrent Statement Of Financial Position Extensible Enumeration DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2023Q1	us-gaap	Derivative Liability Current Statement Of Financial Position Extensible Enumeration DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent
CY2022Q2	us-gaap	Derivative Liability Current Statement Of Financial Position Extensible Enumeration DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-15317
	dei	Entity Registrant Name EntityRegistrantName	ResMed Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0152841
	dei	Entity Address Address Line1 EntityAddressAddressLine1	9001 Spectrum Center Blvd.
	dei	Entity Address City Or Town EntityAddressCityOrTown	San Diego
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92123
	dei	Entity Address Country EntityAddressCountry	US
	dei	City Area Code CityAreaCode	858
	dei	Local Phone Number LocalPhoneNumber	836-5000
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.004 per share
	dei	Trading Symbol TradingSymbol	RMD
	dei	Security Exchange Name SecurityExchangeName	NYSE
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	146930660	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	227894000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	273710000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	24852000	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	23259000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	686264000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	575950000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	1011269000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	743910000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	412388000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	337908000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	2337815000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	1931478000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	528778000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	498181000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	127508000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	132314000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	2783624000	usd
CY2022Q2	us-gaap	Goodwill Goodwill	1936442000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	569678000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	345944000	usd
CY2023Q1	us-gaap	Deferred Income Taxes And Other Assets Noncurrent DeferredIncomeTaxesAndOtherAssetsNoncurrent	95603000	usd
CY2022Q2	us-gaap	Deferred Income Taxes And Other Assets Noncurrent DeferredIncomeTaxesAndOtherAssetsNoncurrent	79746000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	270873000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	171748000	usd
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	4376064000	usd
CY2022Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	3164375000	usd
CY2023Q1	us-gaap	Assets Assets	6713879000	usd
CY2022Q2	us-gaap	Assets Assets	5095853000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	161896000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	159245000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	347354000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	344722000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	23129000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	21856000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	141043000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	108667000	usd
CY2023Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	78368000	usd
CY2022Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	44893000	usd
CY2023Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	9901000	usd
CY2022Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	9916000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	761691000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	689299000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	108875000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	95455000	usd
CY2023Q1	us-gaap	Deferred Income Taxes And Other Tax Liabilities Noncurrent DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent	113015000	usd
CY2022Q2	us-gaap	Deferred Income Taxes And Other Tax Liabilities Noncurrent DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent	9714000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	115090000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	120453000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	69553000	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5974000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	1575963000	usd
CY2022Q2	us-gaap	Long Term Debt LongTermDebt	765325000	usd
CY2023Q1	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	37183000	usd
CY2022Q2	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	48882000	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2019679000	usd
CY2022Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1045803000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	2781370000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	1735102000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.004
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.004
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	188760643	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	146924409	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	188246955	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	146410721	shares
CY2023Q1	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	588000	usd
CY2022Q2	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	586000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1728997000	usd
CY2022Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1682432000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	4088057000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	3613736000	usd
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	41836234	shares
CY2022Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	41836234	shares
CY2023Q1	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	1623256000	usd
CY2022Q2	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	1623256000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-261877000	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-312747000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	3932509000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	3360751000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6713879000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5095853000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1116898000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	864500000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3100936000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2663390000	usd
CY2023Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	490824000	usd
CY2022Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	362321000	usd
	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	1340660000	usd
	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	1128314000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	8322000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10982000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	22001000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	33271000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	499146000	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	373303000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1362661000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1161585000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	617752000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	491197000	usd
	us-gaap	Gross Profit GrossProfit	1738275000	usd
	us-gaap	Gross Profit GrossProfit	1501805000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	228457000	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	182401000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	633317000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	544483000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	76436000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	66801000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	209498000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	189258000	usd
CY2023Q1	rmd	Amortization Of Acquired Intangible Assets1 AmortizationOfAcquiredIntangibleAssets1	12188000	usd
CY2022Q1	rmd	Amortization Of Acquired Intangible Assets1 AmortizationOfAcquiredIntangibleAssets1	7730000	usd
	rmd	Amortization Of Acquired Intangible Assets1 AmortizationOfAcquiredIntangibleAssets1	29701000	usd
	rmd	Amortization Of Acquired Intangible Assets1 AmortizationOfAcquiredIntangibleAssets1	23175000	usd
CY2023Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	usd
CY2022Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	9157000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	317081000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	256932000	usd
	us-gaap	Operating Expenses OperatingExpenses	881673000	usd
	us-gaap	Operating Expenses OperatingExpenses	756916000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	300671000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	234265000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	856602000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	744889000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-14964000	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-5462000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-32436000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-16770000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-183000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2627000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-5037000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-5927000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	6418000	usd
CY2022Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-1735000	usd
	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	11506000	usd
	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-527000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2564000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1878000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5773000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	729000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-11293000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7946000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-31740000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-22495000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	289378000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	226319000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	824862000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	722394000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	56878000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	47307000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	156970000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	138018000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	232500000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	179012000	usd
	us-gaap	Net Income Loss NetIncomeLoss	667892000	usd
	us-gaap	Net Income Loss NetIncomeLoss	584376000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.58
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.22
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.55
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.00
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.58
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.22
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.53
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.97
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.44
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.42
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.32
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.26
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	146914000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	146240000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	146681000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	145969000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	147395000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	146962000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	147400000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	147034000	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	232500000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	179012000	usd
	us-gaap	Net Income Loss NetIncomeLoss	667892000	usd
	us-gaap	Net Income Loss NetIncomeLoss	584376000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-12496000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	0	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-32699000	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	20787000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1046000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	83569000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-30654000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	240791000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	177966000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	718762000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	553722000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	3360751000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2610000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-59000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	16919000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-93381000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	210478000	usd
CY2022Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.44
CY2022Q3	us-gaap	Dividends Dividends	64431000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	3432887000	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5120000	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-29654000	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	16936000	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	16464000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	135960000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	224914000	usd
CY2022Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.44
CY2022Q4	us-gaap	Dividends Dividends	64500000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	3738127000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	983000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-584000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	17832000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	8291000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	232500000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.44
CY2023Q1	us-gaap	Dividends Dividends	64640000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	3932509000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	2885679000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4354000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-195000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	17303000	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-23516000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	203613000	usd
CY2021Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.42
CY2021Q3	us-gaap	Dividends Dividends	61189000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	3026049000	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2378000	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-49830000	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	16723000	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	16101000	usd
CY2021Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-6092000	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	201751000	usd
CY2021Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.42
CY2021Q4	us-gaap	Dividends Dividends	61245000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3145835000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2814000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-2253000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	15861000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1046000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	179012000	usd
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.42
CY2022Q1	us-gaap	Dividends Dividends	61419000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	3278804000	usd
	us-gaap	Net Income Loss NetIncomeLoss	667892000	usd
	us-gaap	Net Income Loss NetIncomeLoss	584376000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	118396000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	122198000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	23967000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	26636000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	51215000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	49265000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-5037000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-5927000	usd
	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	11506000	usd
	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	-527000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	88452000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-98158000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	255091000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	209476000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	86607000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	127977000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	31012000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-277973000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	455863000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	271661000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	85223000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	106192000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	10043000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	17449000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	1011225000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	35915000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	29729000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	16614000	usd
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	3937000	usd
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	6802000	usd
	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	-18961000	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	5309000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1113322000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-174677000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	25649000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	26269000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	30297000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	52278000	usd
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	316000	usd
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1070000000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	160000000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	260000000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	136000000	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	193571000	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	183853000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	611465000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-185862000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	178000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-4631000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-45816000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-93509000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	273710000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	295278000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	227894000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	201769000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	145566000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	432268000	usd
	us-gaap	Interest Paid Net InterestPaidNet	32436000	usd
	us-gaap	Interest Paid Net InterestPaidNet	16770000	usd
	rmd	Noncash Part Of Acquisition Fair Value Of Assets Acquired NoncashPartOfAcquisitionFairValueOfAssetsAcquired	359730000	usd
	rmd	Noncash Part Of Acquisition Fair Value Of Assets Acquired NoncashPartOfAcquisitionFairValueOfAssetsAcquired	8986000	usd
	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	148132000	usd
	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	2492000	usd
	rmd	Goodwill Acquired During Period Increase Decrease GoodwillAcquiredDuringPeriodIncreaseDecrease	803357000	usd
	rmd	Goodwill Acquired During Period Increase Decrease GoodwillAcquiredDuringPeriodIncreaseDecrease	33499000	usd
	rmd	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Equity Interest In Acquiree Held Prior To Combination NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationEquityInterestInAcquireeHeldPriorToCombination	0	usd
	rmd	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Equity Interest In Acquiree Held Prior To Combination NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationEquityInterestInAcquireeHeldPriorToCombination	4078000	usd
	rmd	Deferred Payment Obligations For Acquisitions DeferredPaymentObligationsForAcquisitions	874000	usd
	rmd	Deferred Payment Obligations For Acquisitions DeferredPaymentObligationsForAcquisitions	0	usd
	rmd	Business Acquisition Contingent Consideration Recognized Liability BusinessAcquisitionContingentConsiderationRecognizedLiability	2856000	usd
	rmd	Business Acquisition Contingent Consideration Recognized Liability BusinessAcquisitionContingentConsiderationRecognizedLiability	0	usd
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	1011225000	usd
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	35915000	usd
CY2023Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	22100000	usd
	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	66200000	usd
CY2022Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	19800000	usd
	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	69400000	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1116898000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	864500000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3100936000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2663390000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	44356000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	42306000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	118396000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	122198000	usd
CY2023Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	468817000	usd
CY2022Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	355225000	usd
CY2023Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	3530000	usd
CY2022Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	3077000	usd
CY2023Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	538922000	usd
CY2022Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	385608000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	1011269000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	743910000	usd
CY2023Q1	us-gaap	Prepaid Taxes PrepaidTaxes	117762000	usd
CY2022Q2	us-gaap	Prepaid Taxes PrepaidTaxes	99352000	usd
CY2023Q1	rmd	Prepaid Inventory PrepaidInventory	139116000	usd
CY2022Q2	rmd	Prepaid Inventory PrepaidInventory	107291000	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	155510000	usd
CY2022Q2	us-gaap	Other Assets Current OtherAssetsCurrent	131265000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	412388000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	337908000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1183878000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1131295000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	655100000	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	633114000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	528778000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	498181000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	569678000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	345944000	usd
CY2022Q2	us-gaap	Goodwill Goodwill	1936442000	usd
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	803357000	usd
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	43825000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	2783624000	usd
CY2023Q1	rmd	Marketable Equity Investments Fair Value MarketableEquityInvestmentsFairValue	12115000	usd
CY2022Q2	rmd	Marketable Equity Investments Fair Value MarketableEquityInvestmentsFairValue	9167000	usd
CY2023Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	70640000	usd
CY2022Q2	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	39290000	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	67697000	usd
CY2022Q2	us-gaap	Equity Method Investments EquityMethodInvestments	9918000	usd
CY2023Q1	rmd	Equity Investments Total By Measurement Category EquityInvestmentsTotalByMeasurementCategory	150452000	usd
CY2022Q2	rmd	Equity Investments Total By Measurement Category EquityInvestmentsTotalByMeasurementCategory	58375000	usd
CY2022Q2	rmd	Equity Investments EquityInvestments	58375000	usd
	rmd	Additional Equity Investments AdditionalEquityInvestments	86962000	usd
	rmd	Observable Price Adjustments On Non Marketable Equity Securities ObservablePriceAdjustmentsOnNonMarketableEquitySecurities	12612000	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-2043000	usd
	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	3937000	usd
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	3937000	usd
	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	3000000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-5037000	usd
	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	2583000	usd
CY2023Q1	rmd	Equity Investments EquityInvestments	150452000	usd
CY2021Q2	rmd	Equity Investments EquityInvestments	69240000	usd
	rmd	Additional Equity Investments AdditionalEquityInvestments	5713000	usd
	rmd	Observable Price Adjustments On Non Marketable Equity Securities ObservablePriceAdjustmentsOnNonMarketableEquitySecurities	5367000	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-9666000	usd
	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	3981000	usd
	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	209000	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	52599000	shares
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-5927000	usd
CY2022Q1	rmd	Equity Investments EquityInvestments	68499000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	2500000	usd
	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	7600000	usd
CY2022Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-1700000	usd
	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-4500000	usd
CY2022Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	25889000	usd
CY2021Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	22032000	usd
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	9368000	usd
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	14653000	usd
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	9561000	usd
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	9689000	usd
	us-gaap	Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss	144000	usd
	us-gaap	Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss	41000	usd
CY2023Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	25840000	usd
CY2022Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	27037000	usd
CY2023Q1	rmd	Short Term Debt Gross ShortTermDebtGross	10000000	usd
CY2022Q2	rmd	Short Term Debt Gross ShortTermDebtGross	10000000	usd
CY2023Q1	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	99000	usd
CY2022Q2	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	84000	usd
CY2023Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	9901000	usd
CY2022Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	9916000	usd
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1580000000	usd
CY2022Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	770000000	usd
CY2023Q1	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	4037000	usd
CY2022Q2	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	4675000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	1575963000	usd
CY2022Q2	us-gaap	Long Term Debt LongTermDebt	765325000	usd
CY2023Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1585864000	usd
CY2022Q2	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	775241000	usd
	rmd	Debt To Consolidated Ebitda Ratio DebtToConsolidatedEbitdaRatio	3.50
	rmd	Line Of Credit Facility Collateral Percentage Of Company LineOfCreditFacilityCollateralPercentageOfCompany	0.10
CY2022Q2	us-gaap	Senior Notes SeniorNotes	500000000	usd
CY2023Q1	us-gaap	Senior Notes SeniorNotes	500000000	usd
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	403736000	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	307368000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	290639000	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	232500000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	179012000	usd
	us-gaap	Net Income Loss NetIncomeLoss	667892000	usd
	us-gaap	Net Income Loss NetIncomeLoss	584376000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	146914000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	146240000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	146681000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	145969000	shares
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	481000	shares
CY2022Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	722000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	719000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1065000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	147395000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	146962000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	147400000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	147034000	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.58
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.22
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.55
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.00
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.58
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.22
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.53
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.97
CY2022Q2	rmd	Number Of Patents NumberOfPatents	8	patent
	rmd	Receivables Sold With Limited Recourse ReceivablesSoldWithLimitedRecourse	131800000	usd
	rmd	Receivables Sold With Limited Recourse ReceivablesSoldWithLimitedRecourse	126200000	usd
CY2023Q1	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	29700000	usd
	us-gaap	Loss Contingency Accrual Provision LossContingencyAccrualProvision	1000000	usd
CY2022Q2	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	24200000	usd
CY2022Q2	us-gaap	Loss Contingency Accrual Provision LossContingencyAccrualProvision	2100000	usd
CY2023Q1	us-gaap	Derivative Assets DerivativeAssets	5450000	usd
CY2022Q2	us-gaap	Derivative Assets DerivativeAssets	160000	usd
CY2023Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	61588000	usd
CY2022Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	1947000	usd
CY2023Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	9200000	usd
CY2022Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	usd

Files In Submission

Name	View Source	Status
0000943819-23-000008-index-headers.html	Edgar Link	pending
0000943819-23-000008-index.html	Edgar Link	pending
0000943819-23-000008.txt	Edgar Link	pending
0000943819-23-000008-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
rmd-20230331.htm	Edgar Link	pending
rmd-20230331.xsd	Edgar Link	pending
rmd-20230331xex311.htm	Edgar Link	pending
rmd-20230331xex312.htm	Edgar Link	pending
rmd-20230331xex32.htm	Edgar Link	pending
Show.js	Edgar Link	pending
rmd-20230331_cal.xml	Edgar Link	unprocessable
rmd-20230331_def.xml	Edgar Link	unprocessable
rmd-20230331_lab.xml	Edgar Link	unprocessable
rmd-20230331_pre.xml	Edgar Link	unprocessable
rmd-20230331_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RMD
RESMED INC Stock $rmd

2023 Q2 Form 10-Q Financial Statement

#000094381923000008 Filed on April 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RMD RESMED INC Stock $rmd

2023 Q2 Form 10-Q Financial Statement

#000094381923000008 Filed on April 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RMD
RESMED INC Stock $rmd